An investigation was announced for investors in NASDAQ:KITE shares over potential securities laws violations by Kite Pharma Inc and certain of its directors and officers.
Investors who purchased shares of Kite Pharma Inc (NASDAQ:KITE) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Kite Pharma Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On May 8, 2017, Kite Pharma Inc disclosed that a cancer patient had died in April 2017 from brain swelling following treatment with the Company’s CAR-T therapy KTE-C19. Shares of Kite Pharma Inc (NASDAQ:KITE0 declined on May 9, 2017 to $66.75 per share.
Those who purchased NASDAQ:KITE shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com